ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
Exagen Inc

Exagen Inc (XGN)

3.17
-0.12
(-3.65%)
終了 1月12日 6:00AM
3.16
-0.01
(-0.32%)
取引時間後: 9:59AM

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
3.17
買値
2.97
売値
4.50
出来高
53,305
3.05 日の範囲 3.31
1.3003 52 週間の範囲 6.21
時価総額
前日終値
3.29
始値
3.23
時刻
1
@
3.32
最終取引時間
財務取引量
US$ 168,890
VWAP
3.1684
平均取引量 (3 か月)
119,573
発行済株式数
17,637,278
配当利回り
-
PER
-2.35
1 株当たり利益 (EPS)
-1.34
歳入
52.55M
純利益
-23.69M

Exagen Inc について

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differentia... Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists. 詳細を表示

セクター
Medical Laboratories
業界
Medical Laboratories
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Exagen Inc is listed in the Medical Laboratories sector of the ナスダック市場 with ticker XGN. The last closing price for Exagen was US$3.29. Over the last year, Exagen shares have traded in a share price range of US$ 1.3003 to US$ 6.21.

Exagen currently has 17,637,278 shares in issue. The market capitalisation of Exagen is US$58.03 million. Exagen has a price to earnings ratio (PE ratio) of -2.35.

XGN 最新ニュース

Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD

CARLSBAD, Calif., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Exagen Inc., a leading provider of autoimmune testing, today announced the completion of its 1,000,000th AVISE CTD test, marking a significant...

Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform

CARLSBAD, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Exagen Inc., a leading provider of autoimmune testing, today announced the validation and regulatory submission for approval of new Systemic...

Exagen Inc. to Participate in Fourth Quarter Investor Conferences

CARLSBAD, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced that management will participate in the...

Exagen Inc. Reports Third Quarter 2024 Results

Expanded AVISE® CTD trailing twelve-month average selling priceReduced Adjusted EBITDA loss for first three quarters of 2024Revenue in line with expectations, excluding one-time adjustments...

Exagen to Announce Third Quarter 2024 Results on November 12, 2024

CARLSBAD, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results for the quarter ended September 30, 2024...

Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence

CARLSBAD, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, announced today the acceptance of five abstracts at the 2024 American...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.0642.06052801033.1063.9832008893.46974133CS
4-2.8065-46.95892244625.97656.1931939824.34835724CS
120.3914.02877697842.786.212.381195734.37702043CS
261.2867.72486772491.896.211.78816833.82672768CS
521.0851.67464114832.096.211.3003605703.1930574CS
156-7.82-71.155595996410.9910.991.3003470323.69830765CS
260-21.05-86.9116432724.22271.3003471448.36659285CS

XGN - Frequently Asked Questions (FAQ)

What is the current Exagen share price?
The current share price of Exagen is US$ 3.17
How many Exagen shares are in issue?
Exagen has 17,637,278 shares in issue
What is the market cap of Exagen?
The market capitalisation of Exagen is USD 58.03M
What is the 1 year trading range for Exagen share price?
Exagen has traded in the range of US$ 1.3003 to US$ 6.21 during the past year
What is the PE ratio of Exagen?
The price to earnings ratio of Exagen is -2.35
What is the cash to sales ratio of Exagen?
The cash to sales ratio of Exagen is 1.06
What is the reporting currency for Exagen?
Exagen reports financial results in USD
What is the latest annual turnover for Exagen?
The latest annual turnover of Exagen is USD 52.55M
What is the latest annual profit for Exagen?
The latest annual profit of Exagen is USD -23.69M
What is the registered address of Exagen?
The registered address for Exagen is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Exagen website address?
The website address for Exagen is www.exagen.com
Which industry sector does Exagen operate in?
Exagen operates in the MEDICAL LABORATORIES sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
VRMEVerifyMe Inc
US$ 2.57
(52.98%)
57.83M
WKEYWISeKey International Holdings AG
US$ 10.041
(52.83%)
6.72M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.65M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.17B
INTZIntrusion Inc
US$ 2.8888
(44.44%)
40.61M
IGMSIGM Biosciences Inc
US$ 2.095
(-66.21%)
5.81M
CDTGCDT Environmental Technology Investment Holdings Ltd
US$ 1.87
(-51.30%)
2.28M
MODVModivCare Inc
US$ 6.51
(-47.88%)
2.73M
AIFUAIX Inc
US$ 0.420501
(-47.76%)
7.85M
MRSNMersana Therapeutics Inc
US$ 0.691
(-46.85%)
58.44M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.17B
NVDANVIDIA Corporation
US$ 135.91
(-3.00%)
207.53M
RGTIRigetti Computing Inc
US$ 8.9299
(-11.06%)
178.82M
VMARVision Marine Technologies Inc
US$ 2.14
(40.79%)
175.57M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.65M

最近閲覧した銘柄

Delayed Upgrade Clock